Skip to content
Search
Search
Home
About Us
About APLAR
APLAR Milestones
President Message
Committees
APLAR Directors
Executive Committee
Other Committees
Membership
Member National Organizations
Constitution & Terms of Reference
Membership Application
Membership Update
Academy
APLAR Academy
Governance
Membership
Short Course
Upcoming Course
Past Course
Academy Webinar
Upcoming Webinar
Past Webinar
Grand Round
Upcoming Grand Round
Past Grand Round
Discussion Forum
Grand Round Blackboard
ASPIRE Grant
About APLAR ASPIRE
ASPIRE Core Training Modules
ASPIRE Implementation Toolkit
About SIG
AYR
ABOUT AYR
AYR Board
Committee
AYR Membership
AYR Webinar
Upcoming Webinar
Past Webinar
AYR Blackboard
Discussion Forum
Collaboration
APLAR ESOR
ESOR Application
Post Event Submission
Online Submission
EULAR School of Rheumatology
Exchange Programme
Exchange Programe Application
Online Submission
EULAR Exchange Program
APLAR MNO Patronage
Patronage Application
Online Submission
EULAR Collaborations
Center Of Excellence
APLAR CoEs
New Application
Renew CoE Application
Online Submission
Grants and Awards
Grant
COPCORD Grant
Congress Travel Grant
Research Grant
Fellowship Grant
Award
Master Award
Events
Congress
Upcoming Congress
Past Congress
Events
Upcoming Events
Past Events
Gallery
Publications
Published Journal
SIG Publication
COVID – 19 Publication
IJRD
Voice Of APLAR
Patient Education
Pre-assessment questionnaire – APLAR Scenario
Pre Course Assessment
Step
1
of
3
33%
Salutation
(Required)
Prof
A/Prof
Dr
Mr
Mrs
Mdm
Ms
Profession
(Required)
Doctor
Nurse
Allied Health
Others
Name
(Required)
First
Last
Country
(Required)
Afghanistan
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bonaire, Sint Eustatius and Saba
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos Islands
Colombia
Comoros
Congo
Congo, Democratic Republic of the
Cook Islands
Costa Rica
Croatia
Cuba
Curaçao
Cyprus
Czechia
Côte d'Ivoire
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Eswatini
Ethiopia
Falkland Islands
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island and McDonald Islands
Holy See
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macao
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North Macedonia
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestine, State of
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Romania
Russian Federation
Rwanda
Réunion
Saint Barthélemy
Saint Helena, Ascension and Tristan da Cunha
Saint Kitts and Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Sint Maarten
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen
Sweden
Switzerland
Syria Arab Republic
Taiwan
Tajikistan
Tanzania, the United Republic of
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkmenistan
Turks and Caicos Islands
Tuvalu
Türkiye
US Minor Outlying Islands
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Uzbekistan
Vanuatu
Venezuela
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis and Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
Åland Islands
Country
Instituition
(Required)
Email
(Required)
Pre-assessment questionnaire
1. Years of practicing rheumatology after medical training
(Required)
1-3 years
3-6 years
6-10 years
>10 years
2. Years of acquiring the skill in musculoskeletal ultrasound
(Required)
<1 year
1-3 year
3-6 year
6-10 year
>10 year
3. Number of rheumatology ultrasound courses attended
(Required)
4. Level of rheumatology ultrasound achieved
(Required)
Basic
Intermediate
Advance
Trainer
5. Format of ultrasound courses attended
(Required)
EULAR or EULAR Endorsed Course
International Course
National musculoskeletal / rheumatology ultrasound course
Sonoanatomy
Disease specific e.g. rheumatoid arthritis, vasculitis etc
Only face-to-face course
Only online course
Both (online and face-to-face) courses
Other:
Other:
(Required)
6. Availability of ultrasound in the clinic for point of care use
(Required)
Yes
No
7. Number of ultrasound scans performed per month
(Required)
Current use of Ultrasound
1. Do you currently use ultrasound for assessment in your patients?
(Required)
Yes
No
2. Do you perform
(Required)
a. MSK US
b. Vascular US
c. Both MSK and vascular US
3. What is the main reason you have requested or performed ultrasound?
(Required)
a) Confirming or disproving clinical assessment findings
b) For diagnostic purposes for synovitis, tenosynovitis, enthesitis or any other inflammatory findings to confirm /exclude an inflammatory rheumatology condition
c) For diagnostic purposes to confirm/exclude the diagnosis in suspected GCA or large vessel vasculitis
d) For diagnostic and assessment purposes in patients presenting with polymyalgia
e) To assess disease activity in managing clinical remission (please state which diseases)
f) To assess disease activity to help with determining concomitant non-inflammatory causes before changing therapy (such as osteoarthritis or fibromyalgia)
g) To assess disease activity to aid patient education (such as to improve medication adherence or compliance)
h) For guiding injections
i) Other (please specify)
Other
(Required)
4. Do you use ultrasound in the following areas?
(Required)
a) As part of clinical care in a separate dedicated ultrasound clinic
b) At the bedside or during ward rounds as point of care ultrasound
c) For teaching
d) For research
e) Other (please state)
Other 4
(Required)
5. What are the perceived barriers in using ultrasound more frequently in practice?
(Required)
a) Time constraints in clinical practice
b) Cost of ultrasound machine
c) Cost of sonographer time
d) Lack of experience in ultrasound
e) Lack of training in ultrasound
f) Other:
Other 5
(Required)
6. Do you discuss ultrasound imaging findings with patients?
(Required)
Yes
No
7. Do you give a report/document about your findings to
a. The patient
b. other doctors
c. regulatory body (hospital etc)
8. Does ultrasound help you with diagnosis and management in terms of adding to post-test probability ( in addition to the history, clinical examination and laboratory findings)?
(Required)
Yes
No